We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Precigen
PGEN
$1.94B
| $821K | ﹤0.01% |
387,311
-52,600
| -12% | -$111K |
|
1627
Trinity Industries
TRN
$2.92B
| $818K | ﹤0.01% |
38,300
-27,000
| -41% | -$660K |
|
1628
Washington Trust Bancorp
WASH
$748M
| $818K | ﹤0.01% |
17,600
+8,600
| +96% | +$440K |
|
1629
Amerant Bancorp
AMTB
$1.16B
| $815K | ﹤0.01% |
32,800
-14,900
| -31% | -$406K |
|
1630
Agilysys
AGYS
$3.21B
| $814K | ﹤0.01% |
14,700
-3,900
| -21% | -$197K |
|
1631
Procore
PCOR
$7.57B
| $811K | ﹤0.01% |
16,400
+4,700
| +40% | +$253K |
|
1632
Verastem
VSTM
$528M
| $810K | ﹤0.01% |
79,425
-8,375
| -10% | -$117K |
|
|
AMRN
1633
Amarin Corp
AMRN
$297M
| $807K | ﹤0.01% |
37,015
+21,930
| +145% | +$588K |
|
|
HSII
1634
DELISTED
Heidrick & Struggles
HSII
| $807K | ﹤0.01% |
31,057
+13,000
| +72% | +$384K |
|
1635
Cal-Maine
CALM
$4.43B
| $805K | ﹤0.01% |
14,484
-23,700
| -62% | -$1.3M |
|
1636
Bread Financial
BFH
$4.32B
| $802K | ﹤0.01% |
25,500
+400
| +2% | +$15.7K |
|
1637
Enpro
NPO
$6.26B
| $799K | ﹤0.01% |
9,400
+900
| +11% | +$81.9K |
|
1638
MiMedx Group
MDXG
$630M
| $797K | ﹤0.01% |
277,800
+65,100
| +31% | +$231K |
|
1639
Preformed Line Products
PLPC
$1.39B
| $797K | ﹤0.01% |
11,200
-800
| -7% | -$56.3K |
|
1640
Relmada Therapeutics
RLMD
$540M
| $796K | ﹤0.01% |
+21,500
| New | +$596K |
|
1641
Silvercrest Asset Management
SAMG
$76.7M
| $796K | ﹤0.01% |
48,700
+1,600
| +3% | +$28.5K |
|
1642
Petco
WOOF
$797M
| $795K | ﹤0.01% |
71,200
+34,200
| +92% | +$500K |
|
1643
Matrix Service
MTRX
$312M
| $794K | ﹤0.01% |
191,800
-98,900
| -34% | -$507K |
|
1644
Qorvo
QRVO
$7.9B
| $794K | ﹤0.01% |
+10,000
| New | +$967K |
|
1645
Church & Dwight Co
CHD
$23.7B
| $793K | ﹤0.01% |
11,100
-49,800
| -82% | -$4.3M |
|
1646
Axos Financial
AX
$5.58B
| $788K | ﹤0.01% |
23,016
+9,100
| +65% | +$368K |
|
1647
American Public Education
APEI
$940M
| $787K | ﹤0.01% |
+86,100
| New | +$1.07M |
|
1648
SiriusPoint
SPNT
$3.03B
| $786K | ﹤0.01% |
158,700
+111,600
| +237% | +$519K |
|
1649
Astronics
ATRO
$3.21B
| $785K | ﹤0.01% |
119,880
-46,440
| -28% | -$387K |
|
|
NOVA
1650
DELISTED
Sunnova Energy
NOVA
| $782K | ﹤0.01% |
+35,400
| New | +$859K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.